MDS-ES Visiting Trainee Program Host Sites

European Centers Hosting Trainee Grant Programs

MDS Members are encouraged to apply to have their center listed to be considered by Visiting Trainees. The listing will include the center’s expertise and type of programs they may be able to offer.

These placements are not endorsed by or supported in any way by MDS; the listing is provided as a free service by MDS for the benefit of its membership. MDS takes no responsibility for the accuracy of the information listed or the description of the centers.

Placements are not supported financially by MDS. Completion of a program is not acknowledged by any kind of accreditation by the Society.

France
France

CHU Nantes
Philippe Damier, MD, PhD
Clinique Neurologique
F-44093 NANTES
Tel: +33 24 016 5205
Fax: +33-24 016 5203
E-mail: philippe.damier@chu-nantes.fr

Language requirements: French mandatory for clinical program, English for research program.
Activities included in Visiting Trainee Program: Movement disorder outpatient clinic, deep brain stimulation (surgical room, settings), botulinum toxin, movement disorder inpatient clinic (for clinical program more than 3 months).
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa.
Areas of clinical research interest: Clinical trials, cognitive disorders, neuroimaging, neuropsychiatry, Parkinson’s disease, Parkinsonism, MSA, PSP (secondary and parkinsonism-plus), tics/stereotypies, tremor.
Type and duration: Clinical - 1-3 months, 4-6 months and more than 6 months; Research - More than 6 months.
 

CHU Clermont Ferrand
Franck Durif, MD, PhD
Service de Neurologie
CHU Clermont-Ferrand BP 69
63003 Clermontferrand cedex 1
France
Tel: +33 47 375 1598
Secretary: +33 47 375 1594
E-mail: fdurif@chu-clermontferrand.fr

Language requirements: English, French.
Areas in which specific training is offered:
Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, rehabilitation.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, dystonia, Huntington’s disease, myoclonus, neuroimaging, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), restless legs syndrome and other sleep disorders, surgical therapy, tics/stereotypies, tremor.


Institute of Neurodegenerative Diseases
Wassilios Meissner, MD, PhD
Department of Neurology
1 place Amélie Raba-Léon, 33076
Bordeaux, France
Tel: +33 55 782 1253
Fax: +33 55 656 6702
E-mail: wassilios.meissner@chu-bordeaux.fr
Website: www.imnc-bordeaux.org

Language requirements: French preferred, but English also accepted.
Activities included in Visiting Trainee Program: The Institute of Neurodegenerative Diseases offers a broad spectrum of in- and outpatient training activities with multidisciplinary management of patients with PD and movement disorders involving several units:

  • A 12-bed ward dedicated to Movement Disorders (Prof. Tison, Prof. Meissner, Dr. Vergnet)
  • The clinical branch of the Institute of Neurodegenerative Diseases (IMNc, Prof. Tison) that hosts the multidisciplinary outpatient clinic of the regional Expert Centre for PD (Prof. Meissner)
  • A DBS program (Prof. Pierre Burbaud, Prof. Dominique Guehl, Dr. Damon-Perrière)
  • The Bordeaux site of the French Reference Centre for Multiple System Atrophy (Prof. Meissner, Dr. Foubert-Samier + allied health professionals)
  • Competence centres for Huntington’s disease (Prof. Goizet), Progressive Supranuclear Palsy (Prof. Meissner, Dr Auriacombe), Tourette syndrome (Prof. Burbaud) and Wilson’s disease (Prof. Meissner)
  • A botulinum toxin clinic with a large cohort of patients with dystonia (Prof. Burbaud, Prof. Guehl)
  • A neurophysiological laboratory with special interest in PD and Movement Disorders (Prof. Guehl)
  • Several clinical research programs are run at IMNc and the French Reference Centre for MSA (biomarkers, cognition, epidemiology, imaging, sleep, treatment trials including DBS)


Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders, rehabilitation, autonomic function testing.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, epidemiology, genetics, Huntington’s disease, myoclonus, neuroimaging, neuropharmacology, neurophysiology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), restless legs syndrome and other sleep disorders, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical – 1-3 months, 4-6 months and more than 6 months; Research – 1-3 months, 4-6 months and more than 6 months.
 

Toulouse University Hospital
Olivier Rascol, MD, PhD
Department of Clinical Pharmacology and Neurosciences
Faculty of Medicine
37 Allees Jules Guesde, 31000 Toulouse, France
Tel: +33 56 114 5962
Fax: +33 56 125 5116
E-mail: olivier.rascol@univ-tlse3.fr

Language requirements: French.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders, rehabilitation.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, epidemiology, Huntington’s disease, neuroimaging, neuropharmacology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), spasticity, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical 1-3 months, 4-6 months and more than 6 months; Research 1-3 months, 4-6 months and more than 6 months.

Germany
Germany

Ludwig-Maximilians-University
Kai Bötzel, MD
81366 München, Germany
Tel: +089/7095-3673 oder – 0
Fax: +089/7095-3677
Web: www.nefo.med.uni-muenchen.de
E-mail: kboetzel@med.uni-muenchen.de

Language requirements: German required for clinical training; English and/or German necessary for research training.
Activities included in Visiting Trainee program: Diagnosis of movement disorders, treatment (medical surgical), Research: posture and gait in movement disorders, deep brain stimulation, local field potentials, ultrasound of basal ganglia.
Areas in which specific training is offered: Deep brain stimulation, neurophysiology in movement disorders.
Areas of clinical/research interests: Dystonia, myoclonus, neuroimaging, neurophysiology, Parkinson’s disease, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical 1-3 months; Research 4-6 months and more than 6 months.


University of Leipzig
Joseph Classen, MD
Professor of Neurology
Chairman, Department of Neurology
Liebigstr. 20
04103 Leipzig
Germany
Tel: +49 (0) 341 972 4200
Fax: +49 (0) 341 972 4209
E-mail: joseph.classen@medizin.uni-leipzig.de

Language requirements: German, English
Activities included in Visiting Trainee program: Participation in movement disorders clinic, grand rounds, Botulinum toxin treatment, participation in DBS program (theatre, peri- and postoperative management), research schools (IMPRS).
Areas in which specific training is offered: botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, Huntington’s disease, myoclonus, neuroimaging, neurophysiology, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and Parkinsonism-plus), restless legs syndrome and other sleep disorders, surgical therapy, tics/stereotypies, tremor.
Type and duration: Research 4-6 months and more than 6 months.
 

Philipps University of Marburg
Lars Timmermann, MD
Department of Neurology
Rudolf-Bultmann Str. 8
Marburg 35033
Germany
Tel: +49 64 215 865 193
Fax: +49 64 215 865 164
E-mail: lars.timmermann@uk-gm.de

Language requirements: German for clinical and research, where patient contact is required, English for experimental research.
Activities included in Visiting Trainee Program: Clinical: Differential diagnosis – imaging (MRA, PET, SPECT), neurophysiology, deep brain stimulation, pharmacotherapeutical trials (German Parkinson Study Group – Coordination Center); Experimental research: only useful when training program is at least 12 months – some expertise in laboratory techniques in animal research is required. Prodromal and manifest models of Parkinson’s disease in mice, sterotactic surgery – immunohistochemistry, patch clamp electrophysiology.
Areas in which specific training is offered: Apomorphine, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders, neurosurgery, psychiatry, rehabilitation.
Areas of clinical/research interests: Clinical trials, cognitive disorders, neuroimaging, neuropharmacology, neurophysiology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and Parkinsonism-plus), restless legs syndrome and other sleep disorders, surgical therapy, tremor.
Type and duration: Clinical, more than 6 months; Research, more than 6 months.


University of Dresden
Heinz Reichmann, MD, PhD
Chair and Professor of Neurology
Department of Neurology
Fetscher Strasse 74,
D-01307 Dresden, Germany
Tel: +49 351 458 3565
Fax: +49 351 458 4365
E-mail: heinz.reichmann@mailbox.tu-dresden.de

Language requirements: German, English.
Activities included in Visiting Trainee Program: PET, parenchymal sonography, quantitative smell and tremor analysis, modern treatment, lab expertise in mitochondrial energy metabolism and stem cell research, comprehensive PD ward, DBS, apomorphine and Duodopa pumps.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders, rehabilitation.
Areas of clinical/research interests: botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, Huntington’s disease, neuroimaging, neuropharmacology, neurophysiology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and Parkinsonism-plus), restless legs syndrome and other sleep disorders.
Type and duration: Clinical 1-3 months, 4-6 months and more than 6 months; Research 1-3 months, 4-6 months and more than 6 months.

Italy
Italy

Humanitas Research Hospital Milano
Alberto Albanese, MD
Via Celoria 11
20133 Milano
Tel. +39 02 2394 2552
Fax +39 02 2394 2539
E-mail: alberto.albanese@unicatt.it

Language requirements: Italian and English are the official languages of the hospital. Medical training is held in English.
Activities included in Visiting Trainee Program: Dedicated outpatient clinics (hypokinetic syndromes, hyperkinetic syndromes), inpatients, BoNT clinics, DBS.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neuropsychology.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, Huntington’s disease, myoclonus, neuroimaging, neurophysiology, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), spasticity, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical 4-6 months and more than 6 months.
 

Institute of Neurology
Angelo Antonini, MD, PhD
Via Alberoni 70
Venice, Italy
Tel: +39 04 1220 7111
Fax: +39 04 1731 330
E-mail: angelo.antonini@ospedalesancamillo.net

Language requirements: English, Italian, German.
Activities included in Visiting Trainee program: Clinical assessment of patients, definition of rehabilitation protocols, learning how to organize a multidisciplinary team, definition of neuropsychology protocols, cognitive behavioral therapy, use of specific imaging software including MRI, EEG, MEG.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders, rehabilitation.
Areas of clinical/research interests: Botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, epidemiology, genetics, Huntington’s disease, neuroimaging, neuropharmacology, neurophysiology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), pediatric movement disorders, spasticity, surgical therapy, tremor.
Type and duration: Clinical 4-6 months and more than 6 months; Research 4-6 months and more than 6 months.
 

University of Catania
Mario Zappia, MD
Director of Neurologic Clinic
Department of Neurosciences
Via S. Sofia, 78 – 95123 Catania
Italy
Tel: +39 095 716 9392
Fax: +39 095 330 943
E-mail: m.zappia@isn.cnr.it

Language requirements: English.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, Duodopa, neurophysiology in movement disorders, rehabilitation.
Areas of clinical/research interests: Clinical trials, cognitive disorders, epidemiology, neuropharmacology, neurophysiology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), tremor.
Type and duration: Clinical more than 6 months; Research more than 6 months.

The Netherlands
The Netherlands

University Medical Centre Groningen (UMCG)
Marina AJ de Koning-Tijssen
Department of Neurology AB 51
University medical Center Groningen (UMCG)
PO Box 30.001
9700 RB Groningen
The Netherlands
Tel: +31 50 36 12400
Fax: +31 50 36 11707
E-mail: M.A.J.de.Koning-Tijssen@umcg.nl

Language requirements: English, Dutch if possible, but not essential.
Activities included in Visiting Trainee Program: The Movement Disorders section of the UMCG offers a broad spectrum of activities with a special focus on diagnosis and treatment of hyperkinetic movement disorders and the (long term) treatment options in patients with PD. The section includes several adult outpatient clinics, a multidisciplinary pediatric outpatient clinic, a DBS functional surgery program and a botulinum toxin clinic. There is a large expertise in clinical research with a special interest in functional imaging (PET & fMRI), neurophysiological tests (EMG, EEG, LFP, TMS) and neurogenetics.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, deep brain stimulation, Duodopa, neurophysiology in movement disorders, pediatric movement disorders.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, genetics, Huntington’s disease, myoclonus, neuroimaging, neuropharmacology, neurophysiology, neuropsychiatry, Parkinson’s disease, pediatric movement disorders, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical 1-3 months, 4-6 months and more than 6 months; Research 1-3 months, 4-6 months and more than 6 months.

Spain
Spain

Hospital Universitario of Burgos
Avda Islas Baleares, 3, 09006 Burgos, Spain
Esther Cubo Delgado, MD, PhD
Movement Disorders Unit
Neurology Department
Tel:  +34 94 725 6533, ext 353769
E-mail: mcubo@saludcastillayleon.es

Language requirements: Spanish.
Activities included in Visiting Trainee Program: Differential diagnosis of movement disorders, video rounds, journal club.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, Duodopa.
Areas of clinical/research interests: Clinical trials, epidemiology, Huntington’s disease, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), tics/stereotypies, tremor.
Type and duration: Clinical 1-3 months, 4-6 months.
 

Hospital Ramón y Cajal
Juan Carlos Martínez Castrillo
Movement Disorders Unit
Neurology Service
28034 Madrid - Spain
Tel: +34 91 336 8397
Fax: +34 91 336 9016
E-mail: jmartinez.hrc@salud.madrid.org

Language requirements: Spanish and English.
Activities included in Visiting Trainee Program: Clinical Movement Disorder Clinic, botulinum toxin, deep brain stimulation (PD, tremor and dystonia), apomorphine and intestinal levodopa.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, dystonia, epidemiology, Huntington’s disease, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), spasticity, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical 1-3 months, 4-6 months.
 

Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla (IBiS)
Unidad de Trastornos del Movimiento (Movement Disorders Unit)
41013 Seville, Spain
Tel: +34 95 592 3040 (office)/+34 955 923 039 (laboratory)
Fax: +34 95 592 3101
E-mail: pmir@us.es
Website: www.ibis-sevilla.es

Language requirements: Primary language for clinical: Spanish; Primary language for research: English or Spanish.
Activities included in Visiting Trainee Program:
Hyperkinetic movement disorder clinics, Parkinson’s disease and parkinsonisms clinic, movement disorders in patients, surgical procedures, neurophysiological studies in movement disorders, genetic lab, neuroimaging analysis, movement disorders grand rounds.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, deep brain stimulation, Duodopa, neurophysiology in movement disorders, genetics.
Areas of clinical/research interests:
Botulinum toxin treatments, clinical trials, dystonia, genetics, neuroimaging, neurophysiology, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), pediatric movement disorders, surgical therapy, tics/stereotypies.
Type and duration: Clinical 1-3 months, 4-6 months and more than 6 months; Research 1-3 months, 4-6 months and more than 6 months.
 

Fundacion Jiminez Diaz Barcelona
Pedro J Garcia Ruiz, MD, PhD
Avda Reyes Catolicos 2
Madrid 28040, Spain
Tel: +34 91 550 4882
Fax: +34 91 549 7381
E-mail: pgarcia@fjd.es

Language requirements: English (primary), Spanish (important, but not essential).
Activities included in Visiting Trainee Program: Outpatient MD clnical assistance including HD program, DBS, apomorphine infusion and duodopa, botulinum toxin treatments (80 per month average), clinical sessions (hospital and multi-center), clinical research.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, neurophysiology in movement disorders, neuropsychology.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, dystonia, Huntington’s disease, myoclonus, neuropharmacology, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), spasticity, surgical therapy, tics/stereotypies.
Type and duration: Clinical 1-3 months; Research 1-3 months.
 

Hospital de la Santa Creu i Sant Pau
Jaime Kulisevsky, MD, PhD
Sant Antoni M. Claret 167, 08025 Barcelona – Spain
Tel: +34 93 291 9049
Fax: +34 93 455 4681
E-mail: jkulisevsky@santpau.cat

Language requirements: Primary language is Spanish. Trainee must understand and speak Spanish.
Areas in which specific training is offered: Botulinum toxin injections, deep brain stimulation, Duodopa.
Areas of clinical/research interests: Ataxia, botulinum toxin treatments, clinical trials, cognitive disorders, dystonia, Huntington’s disease, neuroimaging, neurophysiology, neuropsychiatry, Parkinson’s disease, parkinsonism, MSA, PSP (secondary and parkinsonism-plus), restless legs syndrome and other sleep disorders, surgical therapy, tics/stereotypies, tremor.
Type and duration: Clinical 1-3 months, 4-6 months; Research 1-3 months, 4-6 months.

United Kingdom
United Kingdom

Imperial College London
Peter Bain, MA, MD, FRCP
Department of Neurology
Tel: +44 20 3311 1182
Fax: +44 20 3311 1253
E-mail: p.bain@imperial.ac.uk or yen.tai@imperial.ac.uk

Language requirements: English.
Activities included in Visiting Trainee Program: Tertiary movement disorders clinics and ward rounds, deep brain stimulation clinics and surgery, active clinical trial unit for movement disorders, botulinum toxin clinics.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, deep brain stimulation, Duodopa, focused ultrasound thalamotomy.
Type and duration: Clinical 1-3 months, 4-6 months or more than 6 months; Research 1-3 months, 4-6 months or more than 6 months.
 

Kings College Hospital
K. Ray Chaudhuri, MD, FRCP, DSc
NPF Centre of Excellence
9th Floor Ruskin Wing
Denmark Hill
London SE5 9RS, UK
Tel: +00 44 207 346 8336
Fax: +00 44 208 333 3093
E-mail: ray.chaudhuri@nhs.net

Language requirements: English.
Activities included in Visiting Trainee Program: Weekly clinics; tertiary, regional and local movement disorders clinics; young onset PD, PD advanced therapies, DBS, Dystonia, Old age PD, Nurse-led clinics, pediatric movement disorders, restless legs syndrome; advanced therapies program: Apomorphine, Levodopa infusion, participation in host non-motor PD program, DBS service, inpatient service, clinical trials, weekly academic meetings.
Areas in which specific training is offered: Apomorphine, botulinum toxin injections, clinical pharmacology of Parkinson’s disease, deep brain stimulation, Duodopa, international non-motor PD program.
Areas of clinical/research interests: Clinical trials, epidemiology, neuroimaging, Parkinson’s disease, restless legs syndrome and other sleep disorders.
Type and duration: Clinical 1-3 months, 4-6 months; Research 4-6 months, more than 6 months.

Top